Table 2.
Echocardiographic parameters of the study group
| Skin AF ≤2.2 | Skin AF >2.2 | P value | |
|---|---|---|---|
| LVEF (%) | 68.80 ± 7.20 | 65.82 ± 8.11 | 0.02 |
| LA diameter (mm) | 35.34 ± 4.01 | 38.91 ± 4.72 | 0.01 |
| E (cm/s) | 74.88 ± 15.62 | 74.37 ± 19.16 | 0.86 |
| A (cm/s) | 87.94 ± 22.28 | 93.80 ± 20.60 | 0.11 |
| E/A ratio | 0.89 ± 0.26 | 0.82 ± 0.24 | 0.11 |
| E’(SW) (cm/s) | 7.54 ± 2.13 | 6.17 ± 1.84 | 0.01 |
| A’(SW) (cm/s) | 10.11 ± 2.08 | 9.44 ± 2.10 | 0.06 |
| E/E’ ratio | 10.73 ± 3.81 | 12.90 ± 4.50 | 0.01 |
| DT (ms) | 212.44 ± 42.20 | 227.85 ± 51.90 | 0.06 |
| LVMI (g/m2.7) | 47.72 ± 11.62 | 61.22 ± 17.76 | 0.01 |
| oLVM/pLVM | 1.21 ± 0.21 | 1.62 ± 0.38 | 0.01 |
Skin AF skin autofluorescence, LVEF left ventricular ejection fraction, LA left atrium, E early diastolic peak velocity, A late diastolic peak velocity, E′ early diastolic peak velocity at septal portion of mitral annulus, A′ late diastolic peak velocity at septal portion of mitral annulus, SW septal wall, DT deceleration time, LVMI left ventricular mass index, oLVM observed left ventricular mass, pLVM predicted left ventricular mass